Evaluation and utility of new CE marked containers (CELLFLEX- MacoPharma) for bone bank
Authors:
- 1 December 2004
- journal article
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 5 (4) , 267-269
Abstract
In order to guarantee the required level of quality for our Bone & Tissue Banking, we evaluated a new CE marked container (CELLFLEX MacoPharma), for packing, transport, processing and storage of bones fortherapeutic use. The use of CE marked containers is mandatory for organ and tissue containers (Medical Device Directive 93/42).We carried out a three-phase study:(1)Evaluation, (2)Implementation, (3)AuditThe product was evaluated for the following criteria:Dash mechanical resistance, Dash air tightness, Dash fragility, Dash capacity.No damage was observed after the storage period, even after immersion in liquid nitrogen. No breakages were observed after provoked impact tests (pots dropped onto the floor). The pot capacity evaluation showed that the inner pot volume (∼500 ml) permits adequate storage of tendons and the majority of bone allografts.In conclusion, this evaluation has shown that the CELLFLEX kit is suitable for long duration preservation of bone allografts even at very low temperature conditions (vapour phase nitrogen). Its format and structure permit preservation of most bone allografts.Keywords
This publication has 2 references indexed in Scilit:
- Pre-transplantation testing: who, when and why?Journal of Hospital Infection, 1999
- Quality issues in skin banking: a reviewBurns, 1998